Response to discussant comments on "NMA, the first 20 years"

A E Ades; Nicky J Welton; Sofia Dias; Deborah M Caldwell; David M Phillippo

doi:10.1002/jrsm.1745

Response to discussant comments on "NMA, the first 20 years"

A E Ades^*, Nicky J Welton, Sofia Dias, Deborah M Caldwell, David M Phillippo

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

Abstract

We respond to discussant comments on our paper "Twenty years of network meta-analysis: Continuing controversies and recent developments" (https://doi.org/10.1002/jrsm.1700) and raise some additional points for consideration, including: the way in which methodological guidance is generated; integration of the estimand framework with evidence synthesis; and implications of the European Joint Clinical Assessment. We ask: what properties are required of population adjustment methods to enable transparent and consistent decision-making? We also ask why individual patient data is not routinely made available to re-imbursement authorities and clinical guideline developers.

Original language	English
Pages (from-to)	751-757
Number of pages	7
Journal	Research Synthesis Methods
Volume	15
Issue number	5
Early online date	26 Jul 2024
DOIs	https://doi.org/10.1002/jrsm.1745
Publication status	Published - 12 Sept 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Research Synthesis Methods published by John Wiley & Sons Ltd.

Access to Document

10.1002/jrsm.1745Licence: CC BY

Handle.net

Persistent link

Cite this

@article{97fab612d60842759993e449eb269e17,

title = "Response to discussant comments on {"}NMA, the first 20 years{"}",

abstract = "We respond to discussant comments on our paper {"}Twenty years of network meta-analysis: Continuing controversies and recent developments{"} (https://doi.org/10.1002/jrsm.1700) and raise some additional points for consideration, including: the way in which methodological guidance is generated; integration of the estimand framework with evidence synthesis; and implications of the European Joint Clinical Assessment. We ask: what properties are required of population adjustment methods to enable transparent and consistent decision-making? We also ask why individual patient data is not routinely made available to re-imbursement authorities and clinical guideline developers.",

author = "Ades, \{A E\} and Welton, \{Nicky J\} and Sofia Dias and Caldwell, \{Deborah M\} and Phillippo, \{David M\}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Research Synthesis Methods published by John Wiley \& Sons Ltd.",

year = "2024",

month = sep,

day = "12",

doi = "10.1002/jrsm.1745",

language = "English",

volume = "15 ",

pages = "751--757",

journal = "Research Synthesis Methods",

issn = "1759-2879",

publisher = "Cambridge University Press",

number = "5",

}

TY - JOUR

T1 - Response to discussant comments on "NMA, the first 20 years"

AU - Ades, A E

AU - Welton, Nicky J

AU - Dias, Sofia

AU - Caldwell, Deborah M

AU - Phillippo, David M

PY - 2024/9/12

Y1 - 2024/9/12

N2 - We respond to discussant comments on our paper "Twenty years of network meta-analysis: Continuing controversies and recent developments" (https://doi.org/10.1002/jrsm.1700) and raise some additional points for consideration, including: the way in which methodological guidance is generated; integration of the estimand framework with evidence synthesis; and implications of the European Joint Clinical Assessment. We ask: what properties are required of population adjustment methods to enable transparent and consistent decision-making? We also ask why individual patient data is not routinely made available to re-imbursement authorities and clinical guideline developers.

AB - We respond to discussant comments on our paper "Twenty years of network meta-analysis: Continuing controversies and recent developments" (https://doi.org/10.1002/jrsm.1700) and raise some additional points for consideration, including: the way in which methodological guidance is generated; integration of the estimand framework with evidence synthesis; and implications of the European Joint Clinical Assessment. We ask: what properties are required of population adjustment methods to enable transparent and consistent decision-making? We also ask why individual patient data is not routinely made available to re-imbursement authorities and clinical guideline developers.

U2 - 10.1002/jrsm.1745

DO - 10.1002/jrsm.1745

M3 - Article (Academic Journal)

C2 - 39054934

SN - 1759-2879

VL - 15

SP - 751

EP - 757

JO - Research Synthesis Methods

JF - Research Synthesis Methods

IS - 5

ER -